Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 798 results for "edward lifesciences"

Edwards Lifesciences (EW) Trading Near $131.38 Resistance Level

The option-trade picking algorithms behind MarketIntelligenceCenter.com's Artifical Intelligence Center have selected a covered-call trade on Edwards Lifesciences Corp (http://www.marketintelligencecenter.com/symbol/EW"EW) that includes 6.25% ... Individual.com, 1 day ago

3 images for "edward lifesciences"

Ask.com, 6 days ago
Orthopedics Today, 1 day ago
PR Newswire, 1 week ago

Edwards Lifesciences Has Returned 20.8% Since SmarTrend Recommendation (EW)

SmarTrend identified an Uptrend for Edwards Lifesciences (NYSE:EW) on October 23rd, 2014 at $106.16. In approximately 3 months, Edwards Lifesciences has returned 20.81% as of today's recent price
 Individual.com6 days ago Uptrend Call Working As Edwards Lifesciences Stock Rises 19.6% (EW)  Individual.com3 weeks ago Edwards Lifesciences Shares Up 22.9% Since SmarTrend's Buy Recommendation (EW)  Individual.com4 weeks ago Edwards Lifesciences Up 24.8% Since SmarTrend Uptrend Call (EW)  Individual.com1 month ago

EDWARDS LIFESCIENCES : Patent Issued for Reduced Dehiscence Annuloplasty Ring

By a News Reporter-Staff News Editor at Cardiovascular Week -- A patent by the inventors Brunnett, William C. ( Mission Viejo, CA ); Curtis, Alison S. ( Irvine, CA ), filed on November 28, 2011 , was published online on January 13, 2015 , according ...
 4 Traders4 days ago Edwards Lifesciences reports February 3  Seeking Alpha1 week ago

Edwards Lifesciences Defies the Rating: Up 5.9% Fails to Respond: Flat Since Last Week's Downgrade

(Financial News Network On) One week ago Edwards Lifesciences (NYSE:EW) was downgraded from Outperform to Market Perform at Northland. Edwards Lifesciences shares are selling at $135.29, 5.9% above the $127.78 price point of one week ago.
 Individual.com2 weeks ago

Edwards Lifesciences Makes a Move: Up 2.1%

Edwards Lifesciences (NYSE:EW), a company whose shares are moving quickly, is trading 2.1% higher to $129.72. The Dow is up 1.0% to 17,543 and the S&P is currently up 1.0%
 Individual.com2 weeks ago Stock Investors Bid Up Shares of Edwards Lifesciences, Up 3.1%  Individual.com1 month ago

Edwards Lifesciences has the Lowest EBITDA Growth in the Health Care Equipment Industry (EW, SNN, THOR, EXAC, SRDX)

Written on Sun, 01/11/2015 - 11:23am By David Diaz Below are the three companies in the Health Care Equipment industry with the lowest EBITDA Growth (next year estimate vs. LTM). EBITDA Growth can be valuable in predicting future cash flow ...
 Comtex SmarTrend2 weeks ago Shares of Edwards Lifesciences Rank the Lowest in Terms of EBITDA Growth in the Health Care Equipment Industry (EW, SNN, THOR, EXAC, MDT)  Individual.com1 month ago Edwards Lifesciences is Among the Companies in the Health Care Equipment Industry with the Best Relative Performance (EW, DXCM, VAR, RMD, BDX)  Comtex SmarTrend1 month ago Idexx Laboratories is Among the Companies in the Health Care Equipment Industry With the Highest Return on Equity (IDXX, BCR, EW, CYBX, VAR)  Comtex SmarTrend1 week ago

Edwards Lifesciences a Gold Standard in the Market

In this article, let's take a look at Edwards Lifesciences Corp. (EW), a $13.62 billion market cap company that makes and markets a comprehensive line of products and services to treat late-stage cardiovascular disease. Key to growth The company ...
 Yahoo! Finance1 month ago

Why the Earnings Streak Will Continue for Edwards Lifesciences (EW)

Looking for a stock that might be in a good position to beat earnings at its next report? Consider Edwards Lifesciences Corp. ( EW ), a firm in the medical instruments industry, which could be a great candidate for another beat. This company has ...
 Yahoo! Finance1 month ago
MassDevice

Edwards Lifesciences : CardioKinetix Completes $50 Million Financing and Signs Agreement With Edwards Lifesciences, Including Exclusive Option to Purchase

By a News Reporter-Staff News Editor at Investment Weekly News -- CardioKinetix, Inc. , a medical device company pioneering a catheter-based treatment for heart failure, announced that it has completed a $50 million financing led by Edwards ...
 4 Traders1 month ago CardioKinetix signs option-to-buy agreement with Edwards Lifesciences; raises $50M | Medtech funding for the week of December 8, 2014  MassDevice1 month ago CardioKinetix Finalizes $50M Financing with Edwards Lifesciences  Individual.com1 month ago CardioKinetix Gets $50 Million Infusion, Inks Accord with Edwards Lifesciences  FDA News1 month ago
[x]  
Medical Design Online

Edwards Lifesciences Invests $50M In Heart Failure Device Startup

By Jof Enriquez Edwards Lifesciences recently announced a $50 million investment in CardioKinetix, a privately-held company developing a novel intracatheter implant for heart failure patients. The financing deal will help CardioKinetix ...
 Medical Design Online1 month ago Edwards Lifesciences Invests $50 Million in New Heart Failure Technology  Investing.com1 month ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less